Devroe Eric 4
4 · Acrivon Therapeutics, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Devroe Eric
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2025-02-14$5.42/sh−724$3,924→ 67,147 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.